Inverse agonist activity of agouti and agouti-related protein

Agouti and agouti-related protein (AgRP) are endogenous antagonists of the melanocortin receptors (MCxR). Previous data showed that recombinant full-length agouti and a synthetic fragment of AgRP, AgRP (83-132), are inverse agonists at the MC1R and MC4R, respectively. This study demonstrates the smaller analogs AgRP (87-120) and ASIP [90-132 (L89Y)], and short peptides Yc[CRFFNAFC]Y and Qc[CRFFRSAC]S are also MC4R inverse agonists. Furthermore, the relative affinity of the series of MC4R ligands for displacement of radiolabeled antagonist 125I-AgRP (86-132) versus radiolabeled agonist 125I-NDP-MSH did not correlate with ligand efficacy, which is more consistent with an induced-fit model than a simple two-state model of MC4R activation. These data shed new light on the determinants and mechanism of inverse agonism at the MC4R.

[1]  W. Wilkison,et al.  Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line. , 1995, Biochemistry.

[2]  B. Katzung.  Basic and Clinical Pharmacology , 1982 .

[3]  Stanley J. Watson,et al.  A biochemical function for attractin in agouti-induced pigmentation and obesity , 2001, Nature Genetics.

[4]  R. Cone,et al.  Agouti and Agouti-related Protein: Analogies and Contrasts* , 2000, The Journal of Biological Chemistry.

[5]  G. Barsh,et al.  Characterization of Agouti-related protein binding to melanocortin receptors. , 1999, Molecular endocrinology.

[6]  T. Kenakin,et al.  Inverse, protean, and ligand‐selective agonism: matters of receptor conformation , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  Ronald W. Davis,et al.  The mouse mahogany locus encodes a transmembrane form of human attractin , 1999, Nature.

[8]  J. Shutter,et al.  Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. , 1997, Genes & development.

[9]  H. Motulsky,et al.  Calculating receptor number from binding experiments using same compound as radioligand and competitor. , 1989, Trends in pharmacological sciences.

[10]  R. Adan,et al.  AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. , 2001, Molecular endocrinology.

[11]  J. Wikberg,et al.  Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats. , 1999, Neuroreport.

[12]  A. Argiolas,et al.  ACTH- and α-MSH-induced grooming, stretching, yawning and penile erection in male rats: Site of action in the brain and role of melanocortin receptors , 2000, Brain Research Bulletin.

[13]  C. Haskell-Luevano,et al.  Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor , 2001, Regulatory Peptides.

[14]  P. Leff,et al.  The two-state model of receptor activation. , 1995, Trends in pharmacological sciences.

[15]  G. Barsh,et al.  High-resolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP(87-132) of the agouti-related protein. , 2001, Biochemistry.

[16]  W. Wilkison,et al.  Melanocortin receptor binding determinants in the agouti protein. , 1998, Biochemistry.

[17]  G. Barsh,et al.  Design, pharmacology, and NMR structure of a minimized cystine knot with agouti-related protein activity. , 2002, Biochemistry.

[18]  G. Barsh,et al.  Effects of recombinant agouti-signaling protein on melanocortin action. , 1997, Molecular endocrinology.

[19]  R. Norton,et al.  The cystine knot structure of ion channel toxins and related polypeptides. , 1998, Toxicon : official journal of the International Society on Toxinology.

[20]  G. Brooker,et al.  Forskolin potentiation of cholera toxin-stimulated cyclic AMP accumulation in intact C6-2B cells. Evidence for enhanced Gs-C coupling. , 1985, Molecular pharmacology.

[21]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[22]  W. Wilkison,et al.  Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti. , 1997, Journal of receptor and signal transduction research.

[23]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[24]  J. Gies,et al.  Inverse agonist activity of pirenzepine at M2 muscarinic acetylcholine receptors , 1999, British journal of pharmacology.

[25]  M. Tota,et al.  ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. , 1997, Biochemical and biophysical research communications.

[26]  Richard P. Woychik,et al.  Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor , 1994, Nature.

[27]  H. Schiöth,et al.  Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119 , 1999, Neuropeptides.

[28]  G. Barsh,et al.  Transgenic Expression of Syndecan-1 Uncovers a Physiological Control of Feeding Behavior by Syndecan-3 , 2001, Cell.

[29]  M. Tota,et al.  Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors. , 1999, Biochemistry.